Journal of Tissue Engineering and Regenerative Medicine , 11(3), 890-899
Retatrutide activates three GLP-1, GIP and glucagon which is why it is described as a triple hormone receptor agonist, or informally as a triple G drug
More research is underway, including clinical trials looking at semaglutides role in preventing Alzheimers disease
Increasing healthcare access, growing patient awareness, and the adoption of advanced therapies are driving market penetration
Nakatani Y, Maeda M, Matsumura M, Shimizu R, Banba N, Aso Y, et al
These drugs mimic the action of naturally occurring GLP-1, a hormone produced in the intestine that plays a crucial role in glucose regulation and appetite control